Skip to menu Skip to content Skip to footer

2025

Conference Publication

The changing face of cystic fibrosis research: challenges of multi-centre microbiology cohort studies

Evans, I., Duplancic, C., Kidd, T., Ballard, E., Thomson, R., Wainwright, C., Bell, S. and O. NTM in CF Investigators (2025). The changing face of cystic fibrosis research: challenges of multi-centre microbiology cohort studies. 2025 North American Cystic Fibrosis Conference, Seattle, WA United States, 22-25 October 2025. Amsterdam, Netherlands: Elsevier. doi: 10.1016/s1569-1993(25)01642-x

The changing face of cystic fibrosis research: challenges of multi-centre microbiology cohort studies

2025

Conference Publication

Mycobacteria acquisition from potable water across the drinking water system in Australia

Ramsay, K., Smith, K., Duplancic, C., Taylor, S., Rogers, G., Wainwright, C., Thomson, R. and Bell, S. (2025). Mycobacteria acquisition from potable water across the drinking water system in Australia. 2025 North American Cystic Fibrosis Conference, Seattle, WA United States, 22-25 October 2025. Amsterdam, Netherlands: Elsevier. doi: 10.1016/s1569-1993(25)01643-1

Mycobacteria acquisition from potable water across the drinking water system in Australia

2025

Conference Publication

The aetiology and epidemiology of nontuberculous mycobacteria (NTM) in Australians with cystic fibrosis

Duplancic, C., Alene, K., Ballard, E., Thomson, R., Wainwright, C., Rogers, G., Clements, A., Floto, A., Bell, S. and O. NTM in CF Investigators (2025). The aetiology and epidemiology of nontuberculous mycobacteria (NTM) in Australians with cystic fibrosis. 2025 North American Cystic Fibrosis Conference, Seattle, WA United States, 22-25 October 2025. Amsterdam, Netherlands: Elsevier. doi: 10.1016/s1569-1993(25)01654-6

The aetiology and epidemiology of nontuberculous mycobacteria (NTM) in Australians with cystic fibrosis

2025

Conference Publication

Adverse events related to study drugs in finding the optimal regimen for Mycobacterium abscessus treatment (FORMaT) trial

Wainwright, C., Hicks, D., Rice, M., Jong, T., Gailer, N., Joshi, S., Wang, X., Burke, A., Thomson, R., Grimwood, K., Bell, S. and Clark, J. (2025). Adverse events related to study drugs in finding the optimal regimen for Mycobacterium abscessus treatment (FORMaT) trial. 48th European Cystic Fibrosis Conference, Milan, Italy, 4-7 June 2025. Amsterdam, Netherlands: Elsevier. doi: 10.1016/j.jcf.2025.03.118

Adverse events related to study drugs in finding the optimal regimen for Mycobacterium abscessus treatment (FORMaT) trial

2025

Conference Publication

Prevalence of nausea and vomiting and anti-emetic use in the tinding the optimal regimen for Mycobacterium abscessus treatment (Format) trial

Wainwright, C., Hicks, D., Rice, M., Jong, T., Joshi, S., Wang, X., Burke, A., Thomson, R., Grimwood, K., Bell, S. and Clark, J. (2025). Prevalence of nausea and vomiting and anti-emetic use in the tinding the optimal regimen for Mycobacterium abscessus treatment (Format) trial. 48th European Cystic Fibrosis Conference, Milan, Italy, 4-7 June 2025. Amsterdam, Netherlands: Elsevier. doi: 10.1016/j.jcf.2025.03.119

Prevalence of nausea and vomiting and anti-emetic use in the tinding the optimal regimen for Mycobacterium abscessus treatment (Format) trial

2025

Conference Publication

Adverse Events Related to Study Drugs in Finding the Optimal Regimen for Mycobacteroides Abscessus Treatment (Format) Trial

Thomson, R., Hicks, D., Rice, M., Jong, T., Gailer, N., Joshi, S., Wang, X., Burke, A. J., Grimwood, K., Bell, S., Clark, J. and Wainwright, C. E. (2025). Adverse Events Related to Study Drugs in Finding the Optimal Regimen for Mycobacteroides Abscessus Treatment (Format) Trial. 52nd Critical Care Congress of the Society of Critical Care Medicine (SCCM), San Francisco, CA United States, 21-24 January 2023. New York, NY United States: American Thoracic Society.

Adverse Events Related to Study Drugs in Finding the Optimal Regimen for Mycobacteroides Abscessus Treatment (Format) Trial

2025

Conference Publication

Adverse Events Related to Study Drugs in Finding the Optimal Regimen for Mycobacteroides Abscessus Treatment (Format) Trial

Thomson, R., Hicks, D., Rice, M., Jong, T., Gailer, N., Joshi, S., Wang, X., Burke, A.J., Grimwood, K., Bell, S., Clark, J. and Wainwright, C.E. (2025). Adverse Events Related to Study Drugs in Finding the Optimal Regimen for Mycobacteroides Abscessus Treatment (Format) Trial. ATS International Conference, San Francisco, CA, United States, 16-21 May 2025. New York, NY United States: American Thoracic Society. doi: 10.1164/ajrccm.2025.211.abstracts.a7278

Adverse Events Related to Study Drugs in Finding the Optimal Regimen for Mycobacteroides Abscessus Treatment (Format) Trial

2024

Conference Publication

Developing a pharmacovigilance framework for an investigator led, non-commercial international adaptive platform trial

Rice, Megan, Hicks, Daniel, Jong, Tiffany, Gailer, Nicolas, Joshi, Sri, Stevens, Luke, Lee, Kate, Thomson, Rachel, Burke, Andrew, Grimwood, Keith, Bell, Scott, Clark, Julia and Wainwright, Claire E. (2024). Developing a pharmacovigilance framework for an investigator led, non-commercial international adaptive platform trial. 15th Australasian Cystic Fibrosis Conference, Brisbane, QLD, Australia, 2–4 August 2024. Richmond, VIC, Australia: John Wiley & Sons.

Developing a pharmacovigilance framework for an investigator led, non-commercial international adaptive platform trial

2024

Conference Publication

Nontuberculous mycobacteria (NTM) in Australians with cystic fibrosis (CF): A national study

Duplancic, Christine, Wainwright, Claire, Thomson, Rachel, Rogers, Geraint, Clements, Archie, Floto, Andre and Bell, Scott (2024). Nontuberculous mycobacteria (NTM) in Australians with cystic fibrosis (CF): A national study. 15th Australasian Cystic Fibrosis Conference, Brisbane, QLD, Australia, 2–4 August 2024. Richmond, VIC, Australia: John Wiley & Sons.

Nontuberculous mycobacteria (NTM) in Australians with cystic fibrosis (CF): A national study

2024

Conference Publication

Developing a pharmacovigilance framework for an investigator-led, non-commercial platform trial – finding the optimal regimen for Mycobacterium abscessus treatment (FORMaT)

Hicks, D., Jong, T., Rice, M., Gailer, N., Joshi, S., Stevens, L., Lee, K., Thomson, R., Burke, A., Grimwood, K., Bell, S., Clark, J. and Wainwright, C.E. (2024). Developing a pharmacovigilance framework for an investigator-led, non-commercial platform trial – finding the optimal regimen for Mycobacterium abscessus treatment (FORMaT). 47th European Cystic Fibrosis Conference, Glasgow, United Kingdom, 5-8 June 2024. Amsterdam, Netherlands: Elsevier. doi: 10.1016/s1569-1993(24)00244-3

Developing a pharmacovigilance framework for an investigator-led, non-commercial platform trial – finding the optimal regimen for Mycobacterium abscessus treatment (FORMaT)

2024

Conference Publication

Mycobacteria acquisition from potable water

Ramsay, K., Smith, K., Carter, R., Clayton, M., Thomson, R. and Bell, S. (2024). Mycobacteria acquisition from potable water. TSANZSRS 2024 The Australia & New Zealand Society of Respiratory Science and The Thoracic Society of Australia and New Zealand (ANZSRS/TSANZ) Annual Scientific Meeting for Leaders in Lung Health & Respiratory Science,, Gold Coast, QLD, Australia, 22-26 March 2024. Richmond, VIC, Australia: John Wiley & Sons. doi: 10.1111/resp.14673

Mycobacteria acquisition from potable water

2023

Conference Publication

In vitro susceptibility testing of imipenem- relebactam and tedizolid against australian mycobacterium abscessus isolates

Burke, A. J., Carter, R., Tolson, C., Congdon, J., Duplancic, C., Bursle, E., Bell, S., Roberts, J. and Thomson, R. (2023). In vitro susceptibility testing of imipenem- relebactam and tedizolid against australian mycobacterium abscessus isolates. ATS 2023 International Conference, Washington, DC USA, 19-24 May 2023. Washington, DC USA: American Thoracic Society. doi: 10.1164/ajrccm-conference.2023.207.1_meetingabstracts.a2968

In vitro susceptibility testing of imipenem- relebactam and tedizolid against australian mycobacterium abscessus isolates

2019

Conference Publication

Mycobacterium abscessus point source outbreak in the local potable water supply affecting people with cystic fibrosis

Stockwell, R. E., Thomson, R., Leong, L. E., Wheeler, N. E., Bryant, J., Wood, M. E., Sherrard, L. J., Carter, R., Tolson, C., Rogers, G., Wainwright, C., Parkhill, J., Floto, R. A. and Bell, S. C. (2019). Mycobacterium abscessus point source outbreak in the local potable water supply affecting people with cystic fibrosis. Annual North American Cystic Fibrosis Conference, Nashville, TN, United States, 31 October - 2 November 2019. Hoboken, NJ, United States: John Wiley & Sons.

Mycobacterium abscessus point source outbreak in the local potable water supply affecting people with cystic fibrosis

2019

Conference Publication

High incidence of non-tuberculous mycobacteria-positive cultures among children with cystic fibrosis in Australia

Duplancic, C., Thomson, R., Wainwright, C. and Bell, S. C. (2019). High incidence of non-tuberculous mycobacteria-positive cultures among children with cystic fibrosis in Australia. 33rd Annual North American Cystic Fibrosis Conference, Nashville, TN United States, 31 October – 2 November 2019. Hoboken, NJ United States: John Wiley & Sons.

High incidence of non-tuberculous mycobacteria-positive cultures among children with cystic fibrosis in Australia

2019

Conference Publication

Influence of Climate Variables on the Rising Incidence of Nontuberculous Mycobacterial (NTM) Infections in Queensland, Australia 2001-2016

Thomson, R., Furuya-Kanamori, L., Coffey, C., Bell, S., Knibbs, L. and Lau, C. (2019). Influence of Climate Variables on the Rising Incidence of Nontuberculous Mycobacterial (NTM) Infections in Queensland, Australia 2001-2016. International Conference of the American-Thoracic-Society, Dallas, TX United States, 17-22 May 2019. New York, NY United States: American Thoracic Society. doi: 10.1164/ajrccm-conference.2019.199.1_meetingabstracts.a2043

Influence of Climate Variables on the Rising Incidence of Nontuberculous Mycobacterial (NTM) Infections in Queensland, Australia 2001-2016

2018

Conference Publication

PREVALENCE OF SHARED <i>MYCOBACTERIUM ABSCESSUS</i> COMPLEX IN THE QUEENSLAND CYSTIC FIBROSIS POPULATION

Stockwell, R. E., Leong, L., Wheeler, N., Bryant, J., Wood, M. E., Sherrard, L., Thomson, R., Rogers, G., Wainwright, C., Parkhill, J., Floto, R. A. and Bell, S. C. (2018). PREVALENCE OF SHARED MYCOBACTERIUM ABSCESSUS COMPLEX IN THE QUEENSLAND CYSTIC FIBROSIS POPULATION. HOBOKEN: WILEY.

PREVALENCE OF SHARED <i>MYCOBACTERIUM ABSCESSUS</i> COMPLEX IN THE QUEENSLAND CYSTIC FIBROSIS POPULATION

2018

Conference Publication

Infection control in Australian and New Zealand cystic fibrosis centres

Stockwell, R., Wood, M., Moore, V and Bell, S. (2018). Infection control in Australian and New Zealand cystic fibrosis centres. ANZSRS/TSANZ Annual Scientific Meeting, Adelaide, Australia, 23-27 March 2018. Richmond, VIC, Australia: Wiley-Blackwell.

Infection control in Australian and New Zealand cystic fibrosis centres

2016

Conference Publication

Within-host whole genome analysis of an antibiotic resistant Pseudomonas aeruginosa strain sub-type in cystic fibrosis

Sherrard, L., Tai, A., Wee, B., Ramsay, K., Kidd, T., Ben Zakour, N., Whiley, D., Beatson, S. and Bell, S. C. (2016). Within-host whole genome analysis of an antibiotic resistant Pseudomonas aeruginosa strain sub-type in cystic fibrosis. Annual North American Cystic Fibrosis Conference, Orlando, FL, United States, 27-29 October 2016. Hoboken, NJ, United States: John Wiley & Sons.

Within-host whole genome analysis of an antibiotic resistant Pseudomonas aeruginosa strain sub-type in cystic fibrosis

2014

Conference Publication

Evidence of Cross-Transmission of a Multidrug Resistant (Mdr) Pseudomonas Aeruginosa Strain in Patient with Cystic Fibrosis (Cf)

Tai, A., Kidd, T., Ramsay, K., Bell, S. and Whiley, D. (2014). Evidence of Cross-Transmission of a Multidrug Resistant (Mdr) Pseudomonas Aeruginosa Strain in Patient with Cystic Fibrosis (Cf). Annual Scientific Meeting of the Thoracic Society of Australia and New Zealand and the Australian and New Zealand Society of Respiratory Science 2014, Adelaide, SA Australia, 4-9 April 2014. Richmond, VIC Australia: Wiley-Blackwell Publishing Asia. doi: 10.1111/resp.12263_10

Evidence of Cross-Transmission of a Multidrug Resistant (Mdr) Pseudomonas Aeruginosa Strain in Patient with Cystic Fibrosis (Cf)

2014

Conference Publication

Spreading the Word: Introducing Pre-Service Teachers to Programming in the K-12 Classroom

Bell, Scott, Frey, Tim and Vasserman, Eugene (2014). Spreading the Word: Introducing Pre-Service Teachers to Programming in the K-12 Classroom. 45th ACM SIGCSE Technical Symposium on Computer Science Education (SIGCSE), Atlanta Ga, Mar 05-08, 2014. NEW YORK: ASSOC COMPUTING MACHINERY. doi: 10.1145/2538862.2538963

Spreading the Word: Introducing Pre-Service Teachers to Programming in the K-12 Classroom